In particular, identification of allelic imbalance and allele-specific expression in CDC73, construction of molecular classification, and identification of WT1 as a potential biomarker are expected to advance the understanding of molecular mechanisms and more efficient diagnosis of parathyroid carcinoma. Here, CDC73 is linked to parathyroid gland carcinoma.